+
India Boosts Pharma-MedTech Innovation with PRIP Workshop
ECONOMY & POLICY

India Boosts Pharma-MedTech Innovation with PRIP Workshop

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilisers, Government of India, held a workshop on the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP) Scheme on March 12, 2025. Senior officials from key government departments participated, including Shri Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); Shri S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr. N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General of CSIR; and Dr. Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, ICMR.

The workshop focused on strengthening India’s innovation ecosystem in pharmaceuticals and medical technology. Shri Amit Agrawal highlighted the sector's rapid growth, noting the rising global share of advanced technologies like antibody-drug conjugates and gene therapy — projected to reach 20% of the top-100 drugs by value by 2030. He also pointed to the remarkable tenfold increase in Indian healthcare and life sciences startups, from 900 in 2020 to over 10,000 in 2024.

The PRIP scheme aims to build on this momentum with support from initiatives like CSIR’s INTENT for clinical trials, ICMR’s MedTech Mitra and Patent Mitra, and funding programs like DST’s Quantum Computing Mission and MeitY’s TIDE 2.0 and SAMRIDH. Leaders from DST, MeitY, DHR, and CSIR stressed the importance of digital health, AI, data-driven technologies, and industry-academia collaboration in driving innovation and commercialisation of research.

The workshop hosted over 100 participants from top scientific institutions, including NIPERs, IITs, CSIR labs, and government bodies, with discussions on emerging pharmaceutical and MedTech trends and strategies to transform research into market-ready products. Participants were invited to submit suggestions via the Expression of Interest (EoI) form on the Department of Pharmaceuticals’ website, open until April 7, 2025.

(PIB)       

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilisers, Government of India, held a workshop on the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP) Scheme on March 12, 2025. Senior officials from key government departments participated, including Shri Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); Shri S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr. N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General of CSIR; and Dr. Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, ICMR.The workshop focused on strengthening India’s innovation ecosystem in pharmaceuticals and medical technology. Shri Amit Agrawal highlighted the sector's rapid growth, noting the rising global share of advanced technologies like antibody-drug conjugates and gene therapy — projected to reach 20% of the top-100 drugs by value by 2030. He also pointed to the remarkable tenfold increase in Indian healthcare and life sciences startups, from 900 in 2020 to over 10,000 in 2024.The PRIP scheme aims to build on this momentum with support from initiatives like CSIR’s INTENT for clinical trials, ICMR’s MedTech Mitra and Patent Mitra, and funding programs like DST’s Quantum Computing Mission and MeitY’s TIDE 2.0 and SAMRIDH. Leaders from DST, MeitY, DHR, and CSIR stressed the importance of digital health, AI, data-driven technologies, and industry-academia collaboration in driving innovation and commercialisation of research.The workshop hosted over 100 participants from top scientific institutions, including NIPERs, IITs, CSIR labs, and government bodies, with discussions on emerging pharmaceutical and MedTech trends and strategies to transform research into market-ready products. Participants were invited to submit suggestions via the Expression of Interest (EoI) form on the Department of Pharmaceuticals’ website, open until April 7, 2025.(PIB)       

Next Story
Real Estate

Shriram Properties Launches ‘Codename: The One’ in Bengaluru

Shriram Properties (SPL), a leading real estate developer focused on the mid-market and mid-premium segments, has announced the launch of its latest residential project under the banner “Codename: The One” in Bengaluru’s Electronic City corridor. This feature-rich gated community will offer 340 spacious 2- and 3-BHK residences, with a total saleable area of approximately 5 lakh square feet and an estimated revenue potential of over Rs 3.5 billion. The project is expected to be developed over a span of more than three years.  Strategically located near the Bommasandra Metro stat..

Next Story
Resources

India Warehousing Show 2025 Closes with Strong Global Presence

The 14th edition of the India Warehousing Show (IWS) 2025 concluded successfully at Yashobhoomi (IICC), Dwarka, drawing participation from over 300 exhibitors across 15 countries and welcoming 15,000+ visitors. Recognised as India’s leading platform for warehousing and logistics excellence, IWS 2025 offered a comprehensive display of cutting-edge automation, sustainable warehousing solutions, and next-gen supply chain technologies. The show was inaugurated by Shri Pankaj Kumar, Joint Secretary – Logistics, DPIIT, Ministry of Commerce and Industry, Government of India. In his opening a..

Next Story
Equipment

MHIET Launches 450kW Gas Cogeneration System with H₂ Co-Firing

Mitsubishi Heavy Industries Engine & Turbocharger (MHIET), part of the Mitsubishi Heavy Industries Group, has launched a new 450kW gas cogeneration system, the SGP M450, jointly developed with Toho Gas Co.,. The system supports hydrogen co-firing at up to 15 vol per cent, with no loss in performance or reliability.  The system is currently available in the Japanese market, and has been developed from the existing GS6R2 city gas engine platform. Key modifications were made to the fuel gas and engine control systems to enable hydrogen co-firing.   Verified through de..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?